Pfizer Animal Health's approved acquisition of several of ScheringPlough Animal Health (SPAH)'s products will enable the latter to complete its acquisition of Organon BioSciences. The European Commission requires SPAH to divest more than 20 of its animal health products in Europe if it were to acquire Organon BioSciences from Akzo Nobel.
Link to this comment:
All Comments (0)